These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17182861)

  • 1. Evaluation of new antituberculosis drugs in mouse models.
    Davies GR; Pym AS; Mitchison DA; Nuermberger EL; Grosset JH
    Antimicrob Agents Chemother; 2007 Jan; 51(1):403; author reply 403-4. PubMed ID: 17182861
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental models of tuberculosis: can we trust the mouse?
    Mitchison DA; Chang KC
    Am J Respir Crit Care Med; 2009 Aug; 180(3):201-2. PubMed ID: 19633156
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of tuberculosis. I. Mycobacterial subpopulations in the lesions and antitubercular drugs].
    Corlan E
    Pneumoftiziologia; 1992; 41(4):231-42. PubMed ID: 1339503
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of action of antituberculosis drugs in standard and short-course chemotherapy regimens.
    Grosset J
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):108-15. PubMed ID: 2999946
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary drug resistance of Mycobacterium tuberculosis to antitubercular drugs and its clinical significance].
    Ianovskaia OM; Poliakova AN; Samuliak ID; Vasilik GV
    Probl Tuberk; 1975; (11):69-71. PubMed ID: 815904
    [No Abstract]   [Full Text] [Related]  

  • 7. [Toward a modern treatment of pulmonary tuberculosis. 2. Bacteriologic and pharmacologic bases and short-term treatment].
    Zegaya M
    Tunis Med; 1984 Nov; 62(7):487-94. PubMed ID: 6442475
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current bacteriologic and clinical aspects of chemo-antibiotic therapy of pulmonary tuberculosis].
    Saltini C; Velluti G; Mantovani P
    Arch Monaldi; 1978; 33(4):251-79. PubMed ID: 116622
    [No Abstract]   [Full Text] [Related]  

  • 9. Course of murine tuberculosis and response to first-line therapy depends on route of infection and inoculum size.
    de Steenwinkel JE; ten Kate MT; de Knegt GJ; Verbrugh HA; van Belkum A; Hernandez-Pando R; Bakker-Woudenberg IA
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1478-84, i. PubMed ID: 22008760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic efficacy of the principal antitubercular drugs: an evaluation by antibiogram].
    Cremonte LG; Mantellini E
    Minerva Med; 1989 Feb; 80(2):153-6. PubMed ID: 2494591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of tuberculosis with controlled viability of Mycobacteria in the sputum].
    Rudoĭ NM; Erkovskaia OIu
    Probl Tuberk; 1978 May; (5):43-7. PubMed ID: 97658
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hixozide, a novel combined antituberculosis preparation].
    Glushkov RG; Sokolova GB
    Antibiot Khimioter; 2008; 53(5-6):11-3. PubMed ID: 19069176
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis treated in the santorium in Abastumani].
    Shilakadze EM; Margadze GKh; Zautashvili MG
    Probl Tuberk; 1975; (3):79. PubMed ID: 124432
    [No Abstract]   [Full Text] [Related]  

  • 14. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
    Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern short-course regimens in the treatment of tuberculosis.
    Fox W
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):122-32. PubMed ID: 2999948
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 17. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M
    Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG; Chukanov VI; Korneev AA
    Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Initial drug resistance as a threat for tuberculosis control: the case of Buenaventura, Colombia].
    Moreira CA; Hernández HL; Arias NL; Castaño MC; Ferro BE; Jaramillos E
    Biomedica; 2004 Jun; 24 Supp 1():73-9. PubMed ID: 15495574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of isolation of drug-resistant Mycobacterium tuberculosis].
    Astionenko AA
    Vrach Delo; 1978 Dec; (12):27-30. PubMed ID: 105475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.